Clinical Study
Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results
Table 2
Treatment characteristics.
| Characteristic | Value |
| Selectivity of 90Y injection: whole liver/lobar/segmental | 0/17/1 | Median (range) activity (GBq) | 2.5 (1.31–7.51) | Median (range) dose to the target volume (Gy) | 117.8 (80.1–164.1) | Median (range) dose to the nontumoral liver (Gy) | 75.5 (26.5–114.5) | Median (range) dose to the lungs (Gy) | 3.8 (0–28.5) | Median (range) dose to the tumour (Gy) | 261.1 (114.5–393.9) | Median (range) pulmonary shunt fraction (%) | 2.4 (0–43.5) | Median (range) dose of controlled patients (complete response + partial response + stable disease) | 284.5 (194.0–393.9) | Median (range) dose of nonresponders patients | 181.5 (114.5–248.6) |
|
|